A phase I study of oral BGJ398 in Asian patients

A phase I study of oral BGJ398 in Asian patients with advanced solid tumor having alterations of the FGF-R pathway

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222231

Enrollment

Registered

2013-09-24

Start date

2013-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : co

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
safety	—

Secondary

Measure	Time frame
efficacy pharmacokinetics	—

Countries

Asia except Japan, Japan

Outcome results